Status:
NOT_YET_RECRUITING
ACT for Methamphetamine Use Disorder in Women and Gender Non-Conforming Individuals
Lead Sponsor:
Centre for Addiction and Mental Health
Conditions:
Methamphetamine Abuse
Methamphetamine-dependence
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to assess the feasibility, acceptability and preliminary effectiveness of Acceptance Commitment Therapy, in conjunction with motivation enhancement, and the use of the ChillTime App, i...
Detailed Description
Women and gender non-conforming (GNC) individuals with methamphetamine use disorder (MUD) are a particularly vulnerable population in need of complex interventions that can address the range of severe...
Eligibility Criteria
Inclusion
- Meet SCID DSM-5 criteria for Methamphetamine Use Disorder
- Over the age of 18
- Female, woman, or non-binary and comfortable participating in women's group
- Capacity to provide informed consent
- Adequate English language abilities
Exclusion
- Experiencing acute or unmedicated psychosis that would reasonably prevent them from engaging in and/or benefiting from the intervention
- Experiencing acute and severe suicidal ideation such that institutionalization and supervised care is warranted
- Experiencing severe cognitive deficits that would reasonably prevent them from consenting, engaging in, and/or benefiting from the intervention
Key Trial Info
Start Date :
March 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05334914
Start Date
March 1 2024
End Date
April 1 2025
Last Update
February 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Addiction and Mental Health
Toronto, Ontario, Canada, M5B 2K3